| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |